menopause glp 1 GLP-1s Reshape Care Januvia for Type 2 Membership Dose:7.50 mg

menopause glp 1 GLP-1s Reshape Care Januvia for Type 2 Membership Dose:7.50 mg

Januvia for Type 2 Diabetes | Uses, Side Effects & Risks

Current trials: The significant phase 3 clinical program assessing the efficacy and safety of semaglutide (SUSTAIN) in type 2 diabetes has been completed

Membership

Dose:7.50 mg

Table 3: Percent (%) of Type 1 Diabetes Patients Experiencing at Least One Episode of Severe Hypoglycemia or Hypoglycemia§ on TRESIBA in Open-Label Adult and Pediatric Clinical Trials *Severe hypoglycemia in pediatric patients: an episode with altered mental status, where the child could not assist in his own care, was semiconscious or unconscious, or in a coma ± convulsions and may require parenteral therapy (glucagon or intravenous glucose)